Crofelemer Powder for Oral Solution Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
Short Bowel SyndromeFunctional Gastrointestinal DisordersPost-Op Complication+2 more
Napo Therapeutics, S.p.A.18 enrolled8 locationsNCT06904872
Recruiting
Phase 2
Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID)
Rare DiseasesCongenital DisordersMicrovillus Inclusion Disease
Napo Pharmaceuticals, Inc.12 enrolled3 locationsNCT06721871